Induced pluripotent stem cells and their implication for regenerative medicine

Cell and Tissue Banking

Volumn 16, Issue 2, 2015, Pages 171-180

  Csobonyeiova, Maria ^a   Polak, Stefan ^a   Koller, Jan ^b   Danisovic, Lubos ^a  

^a Faculty of Natural Sciences   (Slovakia)

^b UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Gene therapy; Induced pluripotent stem cells; Regenerative medicine; Reprogramming

Indexed keywords

ANIMAL; BIOLOGICAL THERAPY; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CYTOLOGY; HUMAN; INDUCED PLURIPOTENT STEM CELL; NERVOUS SYSTEM DISEASES; PHYSIOLOGY; REGENERATIVE MEDICINE;

ANIMALS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NERVOUS SYSTEM DISEASES; REGENERATIVE MEDICINE;

EID: 84939873823     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-014-9462-9     Document Type: Review

References (60)

1. Adamkov M, Halasova E, Rajcani J, Bencat M, Vybohova D, Rybarova S, Galbavy S (2011) Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas. Med Sci Monit 17(3):74–80
2. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321:699–702
3. Apostolou E, Hochedlinger K (2011) iPS cells under attack. Nature 474:165–166
4. Bai Q, Desprat R, Klein B, Lemitre JM, De Vos J (2013) Embryonic stem cells or Induced pluripotent stem celles? A DNA integrity perspective. Curr Gene Ther 13(2):93–98
5. Ben-David U, Benvenisty N (2011) The tumorigenicyty of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 11:268–277
6. Cai S, Chan YS, Kwok-Yan Shum D (2014) Induced pluripotent stem cells and neurological disease models. Acta Physiol Sinica 66(1):55–66
7. Cheng F, Ke Q, Chen F, Bing C, Gao Y, Ye CH, Wang D, Zhang L, Lahn BT, Li W, Xiang AP (2012) Protecting against wayward human induced pluripotent stem cells with a suicide gene. Biomaterials 33:3195–3204
8. Cui CH, Rao L, Cheng L, Xiao L (2009) Generation and application of human iPS cells. Chin Sci Bull 54:9–13
9. Deng W (2010) Induced pluripotent stem cells: path to new medicines. EMBO Rep 11:161–165
10. Diekman BO, Christoforou N, Willard VP, Sun H, Sanchez-Adams J, Leong KW, Guilak F (2012) Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. PNAS 109:19172–19177
11. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CHE, Eggan K (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into moteor neurons. Science 321:1218–1221
12. Drews K, Jozefczuk J, Prigione A, Adjaye J (2012) Human induced pluripotent stem cells: from mechanisms to clinical applications. J Mol Med 90:735–745
13. Durnaoglu S, Genc S, Genc K (2011) Patient-specific pluripotent StemCells in neurological diseases. Stem Cells Int 2011:1–17
14. Ebert AD, Yu J, Rose FF, Mattis VB, Lorson CL, Thomson JA, Svendsen CN (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277–280
15. Federation AJ, Bradner JE, Meissner A (2014) The use of small molecules in somatic-cell reprogramming. Trends Cell Biol 24:179–187
16. Gallegos TF, Sancho-Martinez I, Belmonte JCI (2013) Advances in cellular reprogramming: moving toward a reprieve from immunogenicity. Immunol Lett 155:14–17
17. González F, Boué S, Belmonte JCI (2011) Methods for making induced pluripotent stem cells: reprogramming á la carte. Nature Rev 12:231–242
18. Halasova E, Adamkov M, Matakova T, Vybohova D, Antosova M, Janickova M, Singliar A, Dobrota D, Jakusova V (2013) Expression of Ki-67, Bcl-2, survivin and p53 proteins in patients with pulmonary carcinoma. Adv Exp Med Biol 756:15–21
19. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R (2007) Treatment of sickle cell anemia mouse model with iPS cells generated form autologus skin. Science 318:1920–1923
20. Hanna J, Markoulaki S, Schorderet P, Carey B, Beard B, Wering M, Creyghton M, Steine E, Cassady J, Foreman R, Lenger Ch, Dausman J, Jaenisch R (2008) Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133:250–264
21. Hargus G, Coopera O, Deleidia M, Levya A, Leea K, Marlowa E, Yowa A, Soldnerb F, Hockemeyerb D, Halletta PJ, Osborna T, Jaenisch R, Isacson O (2010) Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. PNAS 107:15921–15926
22. Hou P, Li Y, Zhang X, Liu CH, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, Ge J, Xu J, Zhang Q, Zhao Y, Deng H (2013) Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341(6146):651–654
23. Huang CH, Wu JC (2012) Epigenetic modulation of induced pluripotent stem cells: novel therapies and disease models. Drug Discov Today Dis Models 9(4):e153–e160
24. Kim D, Kim CH, Moon J, Chung Y, Chang M, Han B, Ko S, Yang E, Cha K, Lanza R, Kim K (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4:472–476
25. Ko JY, Kim KI, Park S, Im GI (2014) In vitro chondorgenesis and in vivo repair of osteochondral defect with human induced pluripotent stem cells. Biomaterials 35:3571–3581
26. Lenger CH (2010) IPS cell technology in regenerative medicine. Ann N Y Acad Sci 1192:38–40
27. Li M, Chen M, Han W, Fu X (2010) How far are induced pluripotent stem cells from the clinic? Ageing Res Rev 9:257–264
28. Lu J, Kong X, Luo Ch, Li KK (2013) Application of epigenome-modifying small molecules in induced pluripotent stem cells. Med Res Rev 33(4):790–822
29. Macarthur CC, Fontes A, Ravinder N, Kuninger D, Kaur J, Bailey M, Taliana A, Vemuri MC, Lieu PT (2012) Generation of human-Induced pluripotent stem cells by a nonintegrating RNA sendai virus vector in feeder-free or xeno-free conditions. Stem Cell Int 2012:1–9
30. Masuda S, Wu J, Hishida T, Pandian GN, Sugiyama H, Belmonte JCI (2013) Chemically induced pluripotent stem cells (CiPSCs): a transgene-free approach. J Cell Biol 5:354–355
31. Medvedev SP, Shevchenko AI, Zakian SM (2010) Induced pluripotent stem cells: problems and advantages when applying them in regenerative medicine. Acta Naturae 2(2):18–28
32. Miyoshi N, Ishii I, Nagano H, Haraguchi N, Laksmi Dewi D, Kano Y, Nishikawa SH, Tanemura M, Mimori K, Tanaka F, Saito T, Nishimura J, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y, Mori M (2011) Reprogramming of mouse and human cells to pluripotency using mature MicroRNAs. Cell Stem Cell 8(6):633–638
33. Narsinh K, Narsinh KH, Wu JC (2011) Derivation of induced pluripotent stem cells for cardiovascular disease modeling. Circ Res 108:1146–1156
34. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A (2010) Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120(5):408–416
35. Nie B, Wang H, Laurent T, Ding S (2012) Cellular reprogramming: a small molecule perspective. Curr Opin Cell Biol 24(6):784–792
36. Nsair A, MacLellan WR (2011) Induced pluripotent stem cell for regenerative cardiovascilar therapies and biomedical discovery. Adv Drug Deliv Rev 63:324–330
37. Obokata H, Wakayama T, Sasai Y, Kojima K, Vacanti MP, Niwa H, Yamato M, Vacanti CHA (2014) Stimulus- trigger fate conversion of somatic cells into pluripotency. Nature 505:641–647
38. Oh S, Lee CHK, Cho KJ, Lee K, Cho S, Hong S (2012) Technological progress in generation of induced pluripotent stem cells for clinical application. Sci World J 2012:417809
39. Okita K, Yamanaka S (2014) Induced pluripotent stem cells. In: Lanza R, Atala A (eds) Essential of stem cells biology, 3rd edn. Oxford, UK, pp 369–379
40. Okita K, Nakagawa M, Hong HJ, Ichisaka T, Yamanaka S (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949–953
41. Papapetrou EP, Lee G, Malani N, Setty M, Riviere I, Tirunagari LM, Kadota K, Roth SL, Giardina P, Viale A, Leslie C, Bushman FD, Studer L, Sadelain M (2011) Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 29(1):73–78
42. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451(7175):141–146
43. Pouya A, Satarian L, Kiani S, Javan M, Baharvand H (2011) Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination. PLoS ONE 6(11):e27925
44. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A, Castellá M, Rio P, Sleep E, Gonzale F, Tiscornia G, Garreta E, Aasen T, Veiga A, Verma IM, Surrallés J, Bueren J, Izpisúa Belmonte JC (2009) Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460:53–59
45. Seifinejad A, Tabebordbar M, Baharvand H, Boyer L, Salakdeh GH (2010) Progress and promise towards safe induced pluripotent stem cells for therapy. Stem Cell Rev. 6(2):297–306
46. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris CH, North PE, Dalton S, Duncan SA (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51:297–305
47. Stadtfeld M, Brennand K, Hochedlinger K (2008) Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 18:890–894
48. Sugiura M, Kasama Y, Araki R, Hoki Y, Sunayama M, Uda M, Nakamura M, Ando S, Abe M (2014) Induced pluripotent stem cell generation-associated point mutations arise during the initial stages of the conversion of these cells. Stem Cell Reports 2(1):52–63
49. Takahashi K, Yamanaka S (2013) Induced pluripotent stem cells in medicine and biology. Development 140(12):2457–2461
50. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–972
51. Tanabe K, Takahashi K, Yamanaka S (2014) Induction of pluripotency by defined factors. Proc Jpn Acad Ser B Phys Biol Sci 90(3):83–96
52. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
53. Tsai SY, Clavel C, Kim S, Ang YS, Grisanti L, Lee DF, Kelley K, Rendl M (2010) Oct4 and Klf4 reprogram dermal papilla cells into induced pluripotent stem cells. Stem Cells 28:221–228
54. Tsuji O, Miura K, Okada Y, Fujiyoshia K, Mukaino M, Nagoshi N, Kitamura K, Kumagai G, Nishino M, Tomisato S, Higashi H, Nagaih T, Katoha H, Kohda K, Matsuzaki Y, Yuzaki M, Ikedai E, Toyamab Y, Nakamura M, Yamanaka S, Okano H (2010) Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. PNAS 107:12704–12709
55. Vitale AM, Wolvetang E, Mackay-Sim A (2011) Induced pluripotent stem cells: a new technology to study human disease. Int J Biochem Cell Biol 43:843–846
56. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. PNAS 105(15):5856–5866
57. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104:e30–e41
58. Zhang Y, Li W, Laurent T, Ding S (2012) Small molecules, big roles: the chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci 125:5609–5620
59. Zhao T, Zhang ZN, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474(7350):212–215
60. Zhou Y, Zeng F (2013) Integration-free methods for generating induced pluripotent stem cells. Genomics Proteomics Bioinform 11:284–287